Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 6.80179940 |
2 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.65109103 |
3 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.28418682 |
4 | endocrine pancreas development (GO:0031018) | 6.15582678 |
5 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.13832227 |
6 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.06845806 |
7 | peptide hormone processing (GO:0016486) | 5.94036253 |
8 | COPII vesicle coating (GO:0048208) | 5.82186436 |
9 | protein retention in ER lumen (GO:0006621) | 5.78266714 |
10 | signal peptide processing (GO:0006465) | 5.47684473 |
11 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.70604970 |
12 | positive regulation of insulin secretion (GO:0032024) | 4.70585244 |
13 | sequestering of metal ion (GO:0051238) | 4.68052846 |
14 | glandular epithelial cell differentiation (GO:0002067) | 4.67980170 |
15 | insulin secretion (GO:0030073) | 4.61116300 |
16 | exocrine pancreas development (GO:0031017) | 4.58908829 |
17 | vesicle coating (GO:0006901) | 4.55708339 |
18 | glutamate secretion (GO:0014047) | 4.43137518 |
19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.39274541 |
20 | response to dietary excess (GO:0002021) | 4.35892353 |
21 | synaptic vesicle maturation (GO:0016188) | 4.28789339 |
22 | synaptic vesicle exocytosis (GO:0016079) | 4.25064251 |
23 | regulation of insulin secretion (GO:0050796) | 4.24686726 |
24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.22127716 |
25 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.02267178 |
26 | regulation of oxidative phosphorylation (GO:0002082) | 3.88925977 |
27 | regulation of peptide hormone secretion (GO:0090276) | 3.86697961 |
28 | positive regulation of peptide hormone secretion (GO:0090277) | 3.83853336 |
29 | regulation of peptide secretion (GO:0002791) | 3.82101583 |
30 | negative regulation of insulin secretion (GO:0046676) | 3.81897995 |
31 | ER overload response (GO:0006983) | 3.79799013 |
32 | positive regulation of nuclease activity (GO:0032075) | 3.77937698 |
33 | positive regulation of peptide secretion (GO:0002793) | 3.74656941 |
34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.72085340 |
35 | toxin metabolic process (GO:0009404) | 3.69692040 |
36 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.68854013 |
37 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.68539145 |
38 | cellular potassium ion homeostasis (GO:0030007) | 3.61688294 |
39 | peptide hormone secretion (GO:0030072) | 3.57832610 |
40 | macroautophagy (GO:0016236) | 3.56012214 |
41 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.55971522 |
42 | detection of calcium ion (GO:0005513) | 3.52171580 |
43 | positive regulation of glycolytic process (GO:0045821) | 3.49660100 |
44 | cerebellar granule cell differentiation (GO:0021707) | 3.48872798 |
45 | peptide secretion (GO:0002790) | 3.48622863 |
46 | neurotransmitter secretion (GO:0007269) | 3.46426300 |
47 | regulation of nuclease activity (GO:0032069) | 3.45523520 |
48 | negative regulation of peptide hormone secretion (GO:0090278) | 3.44538394 |
49 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.42831599 |
50 | regulation of hormone secretion (GO:0046883) | 3.40181209 |
51 | negative regulation of peptide secretion (GO:0002792) | 3.38558057 |
52 | cellular zinc ion homeostasis (GO:0006882) | 3.37326150 |
53 | sodium ion export (GO:0071436) | 3.37042668 |
54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35719442 |
55 | cellular response to topologically incorrect protein (GO:0035967) | 3.33780175 |
56 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.33549451 |
57 | fatty acid homeostasis (GO:0055089) | 3.33008758 |
58 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.30117310 |
59 | protein localization to Golgi apparatus (GO:0034067) | 3.27312504 |
60 | cellular response to unfolded protein (GO:0034620) | 3.25982550 |
61 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.24397811 |
62 | response to misfolded protein (GO:0051788) | 3.23132798 |
63 | * nitric oxide mediated signal transduction (GO:0007263) | 3.21859951 |
64 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.19842956 |
65 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.19459519 |
66 | tricarboxylic acid metabolic process (GO:0072350) | 3.18160104 |
67 | response to hexose (GO:0009746) | 3.17755308 |
68 | regulation of peptide transport (GO:0090087) | 3.15718351 |
69 | nucleoside diphosphate catabolic process (GO:0009134) | 3.15318564 |
70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.14521826 |
71 | ER-nucleus signaling pathway (GO:0006984) | 3.12377076 |
72 | GDP-mannose metabolic process (GO:0019673) | 3.11727448 |
73 | response to glucose (GO:0009749) | 3.11603873 |
74 | positive regulation of hormone secretion (GO:0046887) | 3.11241653 |
75 | metanephric nephron tubule development (GO:0072234) | 3.10198487 |
76 | metanephric tubule development (GO:0072170) | 3.10198487 |
77 | response to monosaccharide (GO:0034284) | 3.10126794 |
78 | metanephric nephron epithelium development (GO:0072243) | 3.08814494 |
79 | axon ensheathment in central nervous system (GO:0032291) | 3.06716374 |
80 | central nervous system myelination (GO:0022010) | 3.06716374 |
81 | dendritic spine morphogenesis (GO:0060997) | 3.05455567 |
82 | hormone secretion (GO:0046879) | 3.04272989 |
83 | low-density lipoprotein particle clearance (GO:0034383) | 3.02537669 |
84 | nephron tubule formation (GO:0072079) | 2.98737333 |
85 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.97656660 |
86 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.93971532 |
87 | potassium ion homeostasis (GO:0055075) | 2.93670449 |
88 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.93664029 |
89 | cellular response to glucagon stimulus (GO:0071377) | 2.93069618 |
90 | cellular response to vitamin D (GO:0071305) | 2.91934714 |
91 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.91905480 |
92 | cellular response to cadmium ion (GO:0071276) | 2.91665376 |
93 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.91147836 |
94 | peptidyl-asparagine modification (GO:0018196) | 2.90531892 |
95 | epithelial cell fate commitment (GO:0072148) | 2.89481820 |
96 | growth hormone secretion (GO:0030252) | 2.88320106 |
97 | glucose homeostasis (GO:0042593) | 2.87466014 |
98 | carbohydrate homeostasis (GO:0033500) | 2.87466014 |
99 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.87191767 |
100 | peptide transport (GO:0015833) | 2.85429043 |
101 | regulation of autophagic vacuole assembly (GO:2000785) | 2.85345085 |
102 | hormone transport (GO:0009914) | 2.84876891 |
103 | neuromuscular process controlling posture (GO:0050884) | 2.82726518 |
104 | triglyceride catabolic process (GO:0019433) | 2.82493355 |
105 | response to endoplasmic reticulum stress (GO:0034976) | 2.82337723 |
106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81962435 |
107 | neuronal ion channel clustering (GO:0045161) | 2.81666421 |
108 | metanephric epithelium development (GO:0072207) | 2.80261271 |
109 | cellular response to monosaccharide stimulus (GO:0071326) | 2.78874986 |
110 | cell communication by electrical coupling (GO:0010644) | 2.77036231 |
111 | positive regulation of synapse maturation (GO:0090129) | 2.76025444 |
112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.75246571 |
113 | cellular response to hexose stimulus (GO:0071331) | 2.74557850 |
114 | acylglycerol catabolic process (GO:0046464) | 2.71423915 |
115 | neutral lipid catabolic process (GO:0046461) | 2.71423915 |
116 | regulation of neurotransmitter levels (GO:0001505) | 2.70603943 |
117 | cGMP-mediated signaling (GO:0019934) | 2.70515676 |
118 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.70358388 |
119 | adaptation of signaling pathway (GO:0023058) | 2.69861335 |
120 | positive regulation of p38MAPK cascade (GO:1900745) | 2.68677765 |
121 | neurotransmitter transport (GO:0006836) | 2.67828833 |
122 | potassium ion import (GO:0010107) | 2.67704501 |
123 | protein N-linked glycosylation (GO:0006487) | 2.67034266 |
124 | glandular epithelial cell development (GO:0002068) | 2.66613705 |
125 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.66384845 |
126 | negative regulation of metanephros development (GO:0072217) | 2.65717550 |
127 | regulation of synaptic vesicle transport (GO:1902803) | 2.65147848 |
128 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64368029 |
129 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.64099894 |
130 | regulation of energy homeostasis (GO:2000505) | 2.63002993 |
131 | Golgi vesicle transport (GO:0048193) | 2.62994496 |
132 | peptide metabolic process (GO:0006518) | 2.62828360 |
133 | response to carbohydrate (GO:0009743) | 2.61454890 |
134 | ovulation from ovarian follicle (GO:0001542) | 2.61180967 |
135 | response to topologically incorrect protein (GO:0035966) | 2.59320535 |
136 | vocalization behavior (GO:0071625) | 2.57997862 |
137 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.56991493 |
138 | positive regulation of vesicle fusion (GO:0031340) | 2.55621935 |
139 | response to unfolded protein (GO:0006986) | 2.55453125 |
140 | postsynaptic membrane organization (GO:0001941) | 2.55261579 |
141 | response to redox state (GO:0051775) | 2.54803369 |
142 | positive regulation of metanephros development (GO:0072216) | 2.54683105 |
143 | eating behavior (GO:0042755) | 2.54490141 |
144 | L-amino acid import (GO:0043092) | 2.54177216 |
145 | regulation of p38MAPK cascade (GO:1900744) | 2.53978443 |
146 | cellular response to vitamin (GO:0071295) | 2.53785301 |
147 | positive regulation of neurotransmitter transport (GO:0051590) | 2.53170203 |
148 | regulation of synapse maturation (GO:0090128) | 2.52664831 |
149 | type B pancreatic cell development (GO:0003323) | 2.52017876 |
150 | cardiac conduction (GO:0061337) | 2.51615321 |
151 | cellular copper ion homeostasis (GO:0006878) | 2.51576438 |
152 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.51339465 |
153 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.50529961 |
154 | glycerolipid catabolic process (GO:0046503) | 2.49992253 |
155 | positive regulation of membrane potential (GO:0045838) | 2.48707003 |
156 | energy reserve metabolic process (GO:0006112) | 2.48599407 |
157 | cellular sodium ion homeostasis (GO:0006883) | 2.48511245 |
158 | locomotory exploration behavior (GO:0035641) | 2.48287259 |
159 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46904296 |
160 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.46460825 |
161 | maintenance of protein localization in organelle (GO:0072595) | 2.45335661 |
162 | myelin maintenance (GO:0043217) | 2.44841401 |
163 | neuronal action potential propagation (GO:0019227) | 2.44840752 |
164 | regulation of female receptivity (GO:0045924) | 2.43754315 |
165 | cell communication involved in cardiac conduction (GO:0086065) | 2.41795078 |
166 | regulation of neurotransmitter transport (GO:0051588) | 2.41155802 |
167 | regulation of respiratory system process (GO:0044065) | 2.40722064 |
168 | regulation of synapse structural plasticity (GO:0051823) | 2.39941971 |
169 | regulation of sequestering of triglyceride (GO:0010889) | 2.38059151 |
170 | regulation of neurotransmitter uptake (GO:0051580) | 2.35663767 |
171 | regulation of lipoprotein metabolic process (GO:0050746) | 2.35198313 |
172 | regulation of neurotransmitter secretion (GO:0046928) | 2.34880364 |
173 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.34206234 |
174 | dendritic spine organization (GO:0097061) | 2.33907810 |
175 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.30208380 |
176 | long term synaptic depression (GO:0060292) | 2.29897572 |
177 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.27226679 |
178 | cellular response to gonadotropin stimulus (GO:0071371) | 2.25685932 |
179 | regulation of vesicle fusion (GO:0031338) | 2.25093406 |
180 | response to leptin (GO:0044321) | 2.24771489 |
181 | regulation of synaptic plasticity (GO:0048167) | 2.24296243 |
182 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.23722102 |
183 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.23539892 |
184 | activation of protein kinase A activity (GO:0034199) | 2.22548212 |
185 | neuron projection regeneration (GO:0031102) | 2.20825379 |
186 | signal release (GO:0023061) | 2.20721779 |
187 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.20612735 |
188 | iron coordination entity transport (GO:1901678) | 2.20205471 |
189 | cyclic-nucleotide-mediated signaling (GO:0019935) | 2.19884362 |
190 | nephron tubule development (GO:0072080) | 2.18792587 |
191 | membrane hyperpolarization (GO:0060081) | 2.17217089 |
192 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.17204968 |
193 | exploration behavior (GO:0035640) | 2.16045587 |
194 | regulation of ARF protein signal transduction (GO:0032012) | 2.14679707 |
195 | cAMP-mediated signaling (GO:0019933) | 2.14278923 |
196 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.13348980 |
197 | COPI coating of Golgi vesicle (GO:0048205) | 10.2755317 |
198 | Golgi transport vesicle coating (GO:0048200) | 10.2755317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.94540962 |
2 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.62339061 |
3 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.58213164 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07358061 |
5 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.83030006 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.63035078 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.52928965 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31528765 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31528765 |
10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28149519 |
11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19020337 |
12 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17125095 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16687971 |
14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14560115 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11826824 |
16 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05483837 |
17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01652866 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98489147 |
19 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.96777570 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90396485 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81866410 |
22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.77069490 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67006374 |
24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64536445 |
25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61662198 |
26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59374733 |
27 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58514414 |
28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56933912 |
29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56778660 |
30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54757109 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.54554316 |
32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53105357 |
33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50811055 |
34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49078014 |
35 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.47933020 |
36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46478615 |
37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45703035 |
38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44899937 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44750543 |
40 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38921296 |
41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37716135 |
42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37579036 |
43 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.34883237 |
44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34542505 |
45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.33018276 |
46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31297547 |
47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30939110 |
48 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.30580784 |
49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30330630 |
50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29086713 |
51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28171799 |
52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28071284 |
53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25434081 |
54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25283862 |
55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24830336 |
56 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22384776 |
57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22060336 |
58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22028528 |
59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22013683 |
60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21923226 |
61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21341889 |
62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19956613 |
63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19023894 |
64 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17940752 |
65 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17894336 |
66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17502231 |
67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17333746 |
68 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15643948 |
69 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12872488 |
70 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.12461595 |
71 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10334367 |
72 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09671421 |
73 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09321131 |
74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08621062 |
75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07996302 |
76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06463575 |
77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06406661 |
78 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06346410 |
79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06285757 |
80 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06136628 |
81 | P68_20966046_ChIP-Seq_HELA_Human | 1.05729954 |
82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05712898 |
83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05610797 |
84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05473838 |
85 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05011644 |
86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04948920 |
87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04497768 |
88 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04497768 |
89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03626806 |
90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03537019 |
91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02209187 |
92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99988639 |
93 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99450711 |
94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97007702 |
95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95955000 |
96 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95611326 |
97 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95288489 |
98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94741224 |
99 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.94026936 |
100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93455721 |
101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93078959 |
102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92662959 |
103 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90834515 |
104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90513872 |
105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90364504 |
106 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89714376 |
107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89155174 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89054150 |
109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88926529 |
110 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.88204102 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88033014 |
112 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87507288 |
113 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87414052 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86976450 |
115 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86766329 |
116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86282400 |
117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85912889 |
118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85400830 |
119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85049978 |
120 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84980176 |
121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84877904 |
122 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.84279128 |
123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83076696 |
124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82781764 |
125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82527460 |
126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81644503 |
127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79824058 |
128 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79544770 |
129 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79513161 |
130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79376949 |
131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79098741 |
132 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78711351 |
133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78373141 |
134 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78155775 |
135 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77553203 |
136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.77182821 |
137 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.77008290 |
138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76981569 |
139 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76443790 |
140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76229758 |
141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75028626 |
142 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.73035965 |
143 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72816101 |
144 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.71057875 |
145 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.70427340 |
146 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70367553 |
147 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.70134372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000013_abnormal_adipose_tissue | 5.37024512 |
2 | MP0003283_abnormal_digestive_organ | 4.82950702 |
3 | MP0004043_abnormal_pH_regulation | 4.18291218 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 3.68923574 |
5 | MP0010386_abnormal_urinary_bladder | 3.66732107 |
6 | MP0002909_abnormal_adrenal_gland | 3.61357315 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 3.59305430 |
8 | MP0002877_abnormal_melanocyte_morpholog | 3.58630940 |
9 | MP0003195_calcinosis | 3.40093230 |
10 | MP0002693_abnormal_pancreas_physiology | 3.36129715 |
11 | MP0001944_abnormal_pancreas_morphology | 3.27818406 |
12 | MP0005379_endocrine/exocrine_gland_phen | 3.18423171 |
13 | MP0000003_abnormal_adipose_tissue | 3.05131663 |
14 | MP0005220_abnormal_exocrine_pancreas | 2.76593721 |
15 | MP0002064_seizures | 2.63949967 |
16 | MP0003880_abnormal_central_pattern | 2.62198363 |
17 | MP0000678_abnormal_parathyroid_gland | 2.59646940 |
18 | MP0003183_abnormal_peptide_metabolism | 2.55500404 |
19 | MP0005423_abnormal_somatic_nervous | 2.55443177 |
20 | MP0005645_abnormal_hypothalamus_physiol | 2.42348860 |
21 | MP0009745_abnormal_behavioral_response | 2.36084499 |
22 | MP0003635_abnormal_synaptic_transmissio | 2.34522095 |
23 | MP0003011_delayed_dark_adaptation | 2.25142052 |
24 | MP0002078_abnormal_glucose_homeostasis | 2.24577803 |
25 | MP0002876_abnormal_thyroid_physiology | 2.23047196 |
26 | MP0009046_muscle_twitch | 2.19828853 |
27 | MP0006072_abnormal_retinal_apoptosis | 2.14322811 |
28 | MP0002272_abnormal_nervous_system | 2.13652601 |
29 | MP0005670_abnormal_white_adipose | 2.00735664 |
30 | MP0005646_abnormal_pituitary_gland | 1.99859644 |
31 | MP0003300_gastrointestinal_ulcer | 1.88032792 |
32 | MP0002063_abnormal_learning/memory/cond | 1.83095412 |
33 | MP0004019_abnormal_vitamin_homeostasis | 1.80107158 |
34 | MP0003122_maternal_imprinting | 1.77333708 |
35 | MP0006054_spinal_hemorrhage | 1.76459357 |
36 | MP0003690_abnormal_glial_cell | 1.76170056 |
37 | MP0001765_abnormal_ion_homeostasis | 1.76012218 |
38 | MP0005375_adipose_tissue_phenotype | 1.73525456 |
39 | MP0002572_abnormal_emotion/affect_behav | 1.68799165 |
40 | MP0000462_abnormal_digestive_system | 1.66418500 |
41 | MP0009643_abnormal_urine_homeostasis | 1.61530501 |
42 | MP0003724_increased_susceptibility_to | 1.58392546 |
43 | MP0004264_abnormal_extraembryonic_tissu | 1.56820399 |
44 | MP0008569_lethality_at_weaning | 1.56722611 |
45 | MP0001756_abnormal_urination | 1.54951057 |
46 | MP0002928_abnormal_bile_duct | 1.51007772 |
47 | MP0008961_abnormal_basal_metabolism | 1.48878301 |
48 | MP0001968_abnormal_touch/_nociception | 1.47235499 |
49 | MP0002163_abnormal_gland_morphology | 1.46978896 |
50 | MP0001486_abnormal_startle_reflex | 1.46832445 |
51 | MP0003959_abnormal_lean_body | 1.46805941 |
52 | MP0005535_abnormal_body_temperature | 1.44824413 |
53 | MP0003953_abnormal_hormone_level | 1.41598680 |
54 | MP0002638_abnormal_pupillary_reflex | 1.37351426 |
55 | MP0001661_extended_life_span | 1.37059205 |
56 | MP0004510_myositis | 1.35346747 |
57 | MP0002557_abnormal_social/conspecific_i | 1.34389153 |
58 | MP0001440_abnormal_grooming_behavior | 1.34246525 |
59 | MP0004130_abnormal_muscle_cell | 1.30005467 |
60 | MP0000230_abnormal_systemic_arterial | 1.29724888 |
61 | MP0005058_abnormal_lysosome_morphology | 1.25500160 |
62 | MP0002896_abnormal_bone_mineralization | 1.25023147 |
63 | MP0001905_abnormal_dopamine_level | 1.24600535 |
64 | MP0005448_abnormal_energy_balance | 1.21790875 |
65 | MP0003631_nervous_system_phenotype | 1.19992209 |
66 | MP0002138_abnormal_hepatobiliary_system | 1.18787277 |
67 | MP0004270_analgesia | 1.18513901 |
68 | MP0004133_heterotaxia | 1.16750909 |
69 | MP0004272_abnormal_basement_membrane | 1.12699158 |
70 | MP0009840_abnormal_foam_cell | 1.11683822 |
71 | MP0005636_abnormal_mineral_homeostasis | 1.10862296 |
72 | MP0002971_abnormal_brown_adipose | 1.08683896 |
73 | MP0000613_abnormal_salivary_gland | 1.07522825 |
74 | MP0003075_altered_response_to | 1.06695330 |
75 | MP0001879_abnormal_lymphatic_vessel | 1.02091898 |
76 | MP0005334_abnormal_fat_pad | 1.01339957 |
77 | MP0001501_abnormal_sleep_pattern | 1.00400755 |
78 | MP0002118_abnormal_lipid_homeostasis | 0.98529157 |
79 | MP0005503_abnormal_tendon_morphology | 0.97761223 |
80 | MP0000920_abnormal_myelination | 0.97170341 |
81 | MP0003172_abnormal_lysosome_physiology | 0.96436172 |
82 | MP0005310_abnormal_salivary_gland | 0.96428107 |
83 | MP0002067_abnormal_sensory_capabilities | 0.94427042 |
84 | MP0005551_abnormal_eye_electrophysiolog | 0.94083996 |
85 | MP0004858_abnormal_nervous_system | 0.93694275 |
86 | MP0008872_abnormal_physiological_respon | 0.92959790 |
87 | MP0010368_abnormal_lymphatic_system | 0.91609125 |
88 | MP0005409_darkened_coat_color | 0.91519058 |
89 | MP0002970_abnormal_white_adipose | 0.91176729 |
90 | MP0003634_abnormal_glial_cell | 0.89900764 |
91 | MP0004924_abnormal_behavior | 0.89876435 |
92 | MP0005386_behavior/neurological_phenoty | 0.89876435 |
93 | MP0003879_abnormal_hair_cell | 0.89427726 |
94 | MP0002736_abnormal_nociception_after | 0.87998929 |
95 | MP0005452_abnormal_adipose_tissue | 0.87617170 |
96 | MP0002066_abnormal_motor_capabilities/c | 0.85202309 |
97 | MP0002139_abnormal_hepatobiliary_system | 0.85164360 |
98 | MP0002735_abnormal_chemical_nociception | 0.85113635 |
99 | MP0002822_catalepsy | 0.85015772 |
100 | MP0005167_abnormal_blood-brain_barrier | 0.82383403 |
101 | MP0000751_myopathy | 0.81548584 |
102 | MP0000639_abnormal_adrenal_gland | 0.81474543 |
103 | MP0002229_neurodegeneration | 0.79446738 |
104 | MP0004185_abnormal_adipocyte_glucose | 0.79104545 |
105 | * MP0001502_abnormal_circadian_rhythm | 0.79022177 |
106 | MP0001986_abnormal_taste_sensitivity | 0.78929279 |
107 | MP0004885_abnormal_endolymph | 0.78198424 |
108 | MP0000604_amyloidosis | 0.77567787 |
109 | MP0005666_abnormal_adipose_tissue | 0.76441292 |
110 | MP0006138_congestive_heart_failure | 0.76163688 |
111 | MP0005084_abnormal_gallbladder_morpholo | 0.74397551 |
112 | MP0001963_abnormal_hearing_physiology | 0.74279145 |
113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73456373 |
114 | MP0006036_abnormal_mitochondrial_physio | 0.71830679 |
115 | MP0001851_eye_inflammation | 0.71807880 |
116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71657739 |
117 | MP0002882_abnormal_neuron_morphology | 0.71511622 |
118 | MP0002733_abnormal_thermal_nociception | 0.71318875 |
119 | MP0002249_abnormal_larynx_morphology | 0.71100888 |
120 | MP0000681_abnormal_thyroid_gland | 0.70252308 |
121 | MP0001664_abnormal_digestion | 0.67630701 |
122 | MP0003787_abnormal_imprinting | 0.67361344 |
123 | MP0002734_abnormal_mechanical_nocicepti | 0.64927009 |
124 | MP0005365_abnormal_bile_salt | 0.62423533 |
125 | MP0002234_abnormal_pharynx_morphology | 0.62387893 |
126 | MP0003119_abnormal_digestive_system | 0.60442313 |
127 | MP0005253_abnormal_eye_physiology | 0.59963052 |
128 | MP0006276_abnormal_autonomic_nervous | 0.59914634 |
129 | MP0010329_abnormal_lipoprotein_level | 0.58617486 |
130 | MP0004859_abnormal_synaptic_plasticity | 0.58232808 |
131 | MP0003329_amyloid_beta_deposits | 0.57983441 |
132 | MP0003828_pulmonary_edema | 0.57722291 |
133 | MP0002069_abnormal_eating/drinking_beha | 0.57233462 |
134 | MP0000609_abnormal_liver_physiology | 0.55184900 |
135 | MP0003866_abnormal_defecation | 0.54636747 |
136 | MP0001270_distended_abdomen | 0.54532868 |
137 | MP0000538_abnormal_urinary_bladder | 0.53497263 |
138 | MP0001970_abnormal_pain_threshold | 0.52922002 |
139 | MP0003633_abnormal_nervous_system | 0.52212734 |
140 | MP0009642_abnormal_blood_homeostasis | 0.52157278 |
141 | MP0000631_abnormal_neuroendocrine_gland | 0.51874933 |
142 | MP0004036_abnormal_muscle_relaxation | 0.51588406 |
143 | MP0002295_abnormal_pulmonary_circulatio | 0.51278920 |
144 | MP0003045_fibrosis | 0.50236491 |
145 | MP0004215_abnormal_myocardial_fiber | 0.50103903 |
146 | MP0001919_abnormal_reproductive_system | 0.48560536 |
147 | MP0005332_abnormal_amino_acid | 0.47713780 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.40289907 |
2 | Hypoglycemic seizures (HP:0002173) | 7.39917607 |
3 | Hypoglycemic coma (HP:0001325) | 7.23190482 |
4 | Symptomatic seizures (HP:0011145) | 6.64246190 |
5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.38349855 |
6 | Myokymia (HP:0002411) | 5.44392213 |
7 | Ketoacidosis (HP:0001993) | 5.09064185 |
8 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.69914724 |
9 | Hyperglycemia (HP:0003074) | 4.50359637 |
10 | Decreased circulating renin level (HP:0003351) | 4.49056082 |
11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.48296132 |
12 | Late onset (HP:0003584) | 4.40563284 |
13 | Focal motor seizures (HP:0011153) | 4.27992908 |
14 | Hypomagnesemia (HP:0002917) | 4.25676862 |
15 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.98263469 |
16 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.98263469 |
17 | Abnormal pancreas size (HP:0012094) | 3.91082831 |
18 | Split foot (HP:0001839) | 3.90256851 |
19 | Abnormality of magnesium homeostasis (HP:0004921) | 3.86727849 |
20 | Febrile seizures (HP:0002373) | 3.78291561 |
21 | Absence seizures (HP:0002121) | 3.69993742 |
22 | Insulin resistance (HP:0000855) | 3.68789843 |
23 | Abnormal drinking behavior (HP:0030082) | 3.63833093 |
24 | Polydipsia (HP:0001959) | 3.63833093 |
25 | Hyperactive renin-angiotensin system (HP:0000841) | 3.56687474 |
26 | Focal seizures (HP:0007359) | 3.55521443 |
27 | Large for gestational age (HP:0001520) | 3.48805665 |
28 | Action tremor (HP:0002345) | 3.44406881 |
29 | Generalized aminoaciduria (HP:0002909) | 3.37522220 |
30 | Mucopolysacchariduria (HP:0008155) | 3.36076566 |
31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.36076566 |
32 | Hyperparathyroidism (HP:0000843) | 3.27883667 |
33 | Dysostosis multiplex (HP:0000943) | 3.24487012 |
34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.21452971 |
35 | Ketosis (HP:0001946) | 3.17772058 |
36 | Abnormal eating behavior (HP:0100738) | 3.16249573 |
37 | Oligomenorrhea (HP:0000876) | 3.15421590 |
38 | Hypokalemia (HP:0002900) | 3.14220130 |
39 | Generalized tonic-clonic seizures (HP:0002069) | 3.13358651 |
40 | Obstructive sleep apnea (HP:0002870) | 3.13265790 |
41 | Tetany (HP:0001281) | 3.12687072 |
42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.02027041 |
43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.00269040 |
44 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.00269040 |
45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.00269040 |
46 | Pheochromocytoma (HP:0002666) | 2.98828318 |
47 | Growth hormone excess (HP:0000845) | 2.98160990 |
48 | Dialeptic seizures (HP:0011146) | 2.98081885 |
49 | Lymphangioma (HP:0100764) | 2.92146856 |
50 | Agitation (HP:0000713) | 2.91083177 |
51 | Torticollis (HP:0000473) | 2.89875774 |
52 | Hyperkalemia (HP:0002153) | 2.88649954 |
53 | Hypercortisolism (HP:0001578) | 2.88484143 |
54 | Chronic bronchitis (HP:0004469) | 2.85768209 |
55 | Gout (HP:0001997) | 2.78654458 |
56 | Ventricular fibrillation (HP:0001663) | 2.78116605 |
57 | Limb hypertonia (HP:0002509) | 2.76772313 |
58 | Abnormality of renin-angiotensin system (HP:0000847) | 2.76724063 |
59 | Epileptic encephalopathy (HP:0200134) | 2.75544309 |
60 | Hypokalemic alkalosis (HP:0001949) | 2.71862300 |
61 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.70695287 |
62 | Atonic seizures (HP:0010819) | 2.66043227 |
63 | Menstrual irregularities (HP:0000858) | 2.65256566 |
64 | Abnormality of chloride homeostasis (HP:0011422) | 2.63855857 |
65 | Adrenal overactivity (HP:0002717) | 2.58966502 |
66 | Neuroendocrine neoplasm (HP:0100634) | 2.58283402 |
67 | Focal dystonia (HP:0004373) | 2.56696656 |
68 | Diplopia (HP:0000651) | 2.56167475 |
69 | Abnormality of binocular vision (HP:0011514) | 2.56167475 |
70 | Acanthosis nigricans (HP:0000956) | 2.55212318 |
71 | Cerebral inclusion bodies (HP:0100314) | 2.53963712 |
72 | Thoracolumbar scoliosis (HP:0002944) | 2.52972847 |
73 | Hyperuricemia (HP:0002149) | 2.52619412 |
74 | Increased purine levels (HP:0004368) | 2.52619412 |
75 | Visual hallucinations (HP:0002367) | 2.51940467 |
76 | Polyuria (HP:0000103) | 2.50867225 |
77 | Osteomalacia (HP:0002749) | 2.50482866 |
78 | Craniofacial dystonia (HP:0012179) | 2.49448911 |
79 | Abnormality of potassium homeostasis (HP:0011042) | 2.49424110 |
80 | Neurofibrillary tangles (HP:0002185) | 2.48032202 |
81 | Bronchomalacia (HP:0002780) | 2.45183196 |
82 | Dysautonomia (HP:0002459) | 2.44186295 |
83 | Supranuclear gaze palsy (HP:0000605) | 2.42902693 |
84 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42716373 |
85 | Abnormal urine output (HP:0012590) | 2.41206322 |
86 | Athetosis (HP:0002305) | 2.41005632 |
87 | Papilledema (HP:0001085) | 2.40653920 |
88 | Thyroid-stimulating hormone excess (HP:0002925) | 2.36604871 |
89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35493162 |
90 | Hypotension (HP:0002615) | 2.35089129 |
91 | Ankle clonus (HP:0011448) | 2.34265749 |
92 | Myoglobinuria (HP:0002913) | 2.33964623 |
93 | Abnormality of renal excretion (HP:0011036) | 2.33529170 |
94 | Axonal loss (HP:0003447) | 2.33297008 |
95 | Progressive neurologic deterioration (HP:0002344) | 2.32736495 |
96 | Complement deficiency (HP:0004431) | 2.30566410 |
97 | Hyperaldosteronism (HP:0000859) | 2.29448861 |
98 | Bundle branch block (HP:0011710) | 2.25270950 |
99 | Hyperphosphatemia (HP:0002905) | 2.22279949 |
100 | Hypothermia (HP:0002045) | 2.22039945 |
101 | Hemiplegia (HP:0002301) | 2.21413365 |
102 | Progressive cerebellar ataxia (HP:0002073) | 2.21117212 |
103 | Hepatic necrosis (HP:0002605) | 2.21079487 |
104 | Hyperthyroidism (HP:0000836) | 2.19435201 |
105 | Postural instability (HP:0002172) | 2.19269645 |
106 | Acute hepatic failure (HP:0006554) | 2.18884215 |
107 | Hypercalciuria (HP:0002150) | 2.17855112 |
108 | Renal tubular acidosis (HP:0001947) | 2.16532081 |
109 | Truncal ataxia (HP:0002078) | 2.14546003 |
110 | Hyporeflexia of lower limbs (HP:0002600) | 2.12676788 |
111 | Fibular aplasia (HP:0002990) | 2.12126550 |
112 | Mitral stenosis (HP:0001718) | 2.08704214 |
113 | Intention tremor (HP:0002080) | 2.08620246 |
114 | Prolonged QT interval (HP:0001657) | 2.08477371 |
115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06956059 |
116 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06956059 |
117 | Abnormal protein glycosylation (HP:0012346) | 2.06956059 |
118 | Abnormal glycosylation (HP:0012345) | 2.06956059 |
119 | Bradycardia (HP:0001662) | 2.06868304 |
120 | Sleep apnea (HP:0010535) | 2.06542541 |
121 | Bone cyst (HP:0012062) | 2.06270414 |
122 | Vascular calcification (HP:0004934) | 2.06203364 |
123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04244530 |
124 | Exocrine pancreatic insufficiency (HP:0001738) | 2.04109409 |
125 | Syncope (HP:0001279) | 2.03560486 |
126 | Unilateral renal agenesis (HP:0000122) | 2.03196820 |
127 | Stridor (HP:0010307) | 2.02702949 |
128 | Vacuolated lymphocytes (HP:0001922) | 2.01496773 |
129 | Retinal atrophy (HP:0001105) | 2.01455814 |
130 | Polyphagia (HP:0002591) | 1.99231322 |
131 | Polygenic inheritance (HP:0010982) | 1.98634243 |
132 | Bell-shaped thorax (HP:0001591) | 1.96994220 |
133 | Hemiparesis (HP:0001269) | 1.93468392 |
134 | Heart block (HP:0012722) | 1.93279691 |
135 | Goiter (HP:0000853) | 1.92146790 |
136 | Abdominal distention (HP:0003270) | 1.92053279 |
137 | Neoplasm of the heart (HP:0100544) | 1.90009328 |
138 | Type I diabetes mellitus (HP:0100651) | 1.88135461 |
139 | Dysmetria (HP:0001310) | 1.87957087 |
140 | Abnormal atrioventricular conduction (HP:0005150) | 1.87757347 |
141 | Hyperlipoproteinemia (HP:0010980) | 1.85662264 |
142 | Type I transferrin isoform profile (HP:0003642) | 1.84634965 |
143 | Humeroradial synostosis (HP:0003041) | 1.82885301 |
144 | Synostosis involving the elbow (HP:0003938) | 1.82885301 |
145 | Mutism (HP:0002300) | 1.82858300 |
146 | Dysdiadochokinesis (HP:0002075) | 1.82169734 |
147 | Abnormality of the fovea (HP:0000493) | 1.81442847 |
148 | Neonatal onset (HP:0003623) | 1.81429996 |
149 | Rigidity (HP:0002063) | 1.80366341 |
150 | Metaphyseal dysplasia (HP:0100255) | 1.78933970 |
151 | Atrial fibrillation (HP:0005110) | 1.78233207 |
152 | Wrist flexion contracture (HP:0001239) | 1.77631160 |
153 | Nonprogressive disorder (HP:0003680) | 1.77559133 |
154 | Sudden death (HP:0001699) | 1.77268748 |
155 | Renal salt wasting (HP:0000127) | 1.76865176 |
156 | Abnormal EKG (HP:0003115) | 1.76116682 |
157 | Dicarboxylic aciduria (HP:0003215) | 1.75569974 |
158 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75569974 |
159 | EEG with generalized epileptiform discharges (HP:0011198) | 1.75210107 |
160 | Increased cerebral lipofuscin (HP:0011813) | 1.75031585 |
161 | Maternal diabetes (HP:0009800) | 1.73379656 |
162 | Hypsarrhythmia (HP:0002521) | 1.73073418 |
163 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72904060 |
164 | Primary adrenal insufficiency (HP:0008207) | 1.71255829 |
165 | Abnormality of purine metabolism (HP:0004352) | 1.70565678 |
166 | Anxiety (HP:0000739) | 1.69935753 |
167 | Epileptiform EEG discharges (HP:0011182) | 1.69483112 |
168 | Increased circulating renin level (HP:0000848) | 1.67873343 |
169 | Neoplasm of the adrenal gland (HP:0100631) | 1.66536407 |
170 | Restlessness (HP:0000711) | 1.65299022 |
171 | Prominent metopic ridge (HP:0005487) | 1.65080172 |
172 | Protuberant abdomen (HP:0001538) | 1.63521198 |
173 | Irregular vertebral endplates (HP:0003301) | 1.62966459 |
174 | Glycosuria (HP:0003076) | 1.62202890 |
175 | Abnormality of urine glucose concentration (HP:0011016) | 1.62202890 |
176 | Irritability (HP:0000737) | 1.61047359 |
177 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.60365082 |
178 | Hypophosphatemia (HP:0002148) | 1.60216137 |
179 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.59634942 |
180 | Congenital glaucoma (HP:0001087) | 1.56051286 |
181 | Congenital sensorineural hearing impairment (HP:0008527) | 1.55917417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 6.90434684 |
2 | INSRR | 6.02668603 |
3 | PASK | 5.49236980 |
4 | ERN1 | 3.69819959 |
5 | PRKD3 | 2.98406105 |
6 | WNK3 | 2.81532932 |
7 | EPHA4 | 2.78525794 |
8 | FLT3 | 2.61139362 |
9 | NTRK1 | 2.59682696 |
10 | WNK4 | 2.55424610 |
11 | HIPK2 | 2.31864654 |
12 | MARK1 | 2.29138093 |
13 | BCKDK | 2.18932838 |
14 | TIE1 | 2.12370676 |
15 | NTRK3 | 1.86641922 |
16 | PIK3CG | 1.81066568 |
17 | KDR | 1.78741344 |
18 | EPHA3 | 1.76695512 |
19 | PDGFRA | 1.72352007 |
20 | NTRK2 | 1.68867629 |
21 | MAP3K2 | 1.64788287 |
22 | MAPK12 | 1.62491824 |
23 | PINK1 | 1.60487606 |
24 | MAP2K2 | 1.46898147 |
25 | STK39 | 1.46521978 |
26 | ABL2 | 1.46236075 |
27 | TRIB3 | 1.45265505 |
28 | PHKG2 | 1.40655214 |
29 | PHKG1 | 1.40655214 |
30 | PKN1 | 1.37734923 |
31 | LATS2 | 1.37649485 |
32 | PRPF4B | 1.37636548 |
33 | MET | 1.33713633 |
34 | SGK494 | 1.30475579 |
35 | SGK223 | 1.30475579 |
36 | PAK3 | 1.30454105 |
37 | FRK | 1.29756499 |
38 | MAPKAPK3 | 1.28441859 |
39 | STK38 | 1.23420707 |
40 | PTK2 | 1.20505745 |
41 | CAMKK2 | 1.15307233 |
42 | DMPK | 1.14200191 |
43 | FER | 1.10488737 |
44 | DYRK1B | 1.10198418 |
45 | PDPK1 | 1.08792981 |
46 | IRAK1 | 1.07497547 |
47 | CAMK2G | 1.00952551 |
48 | LIMK1 | 0.97453238 |
49 | TESK1 | 0.96799193 |
50 | FGFR2 | 0.96249772 |
51 | TAOK2 | 0.96167135 |
52 | MAP3K1 | 0.95409363 |
53 | MAP3K9 | 0.93892742 |
54 | CAMK2A | 0.93406789 |
55 | MARK2 | 0.93200147 |
56 | GRK1 | 0.93013948 |
57 | BRSK1 | 0.92245275 |
58 | KSR2 | 0.85729239 |
59 | CDC42BPA | 0.85618702 |
60 | PDK1 | 0.85552742 |
61 | UHMK1 | 0.84594252 |
62 | MINK1 | 0.83320783 |
63 | ERBB2 | 0.82246121 |
64 | DAPK3 | 0.81036154 |
65 | EPHA2 | 0.80907928 |
66 | SGK2 | 0.79462760 |
67 | PRKCH | 0.79180025 |
68 | MAPK4 | 0.78584556 |
69 | PRKD2 | 0.78322285 |
70 | MAP2K1 | 0.77734057 |
71 | LMTK2 | 0.77366280 |
72 | SCYL2 | 0.76534586 |
73 | SIK1 | 0.75105108 |
74 | MAP3K11 | 0.75014818 |
75 | CASK | 0.73863703 |
76 | EPHB1 | 0.69395526 |
77 | KIT | 0.69361491 |
78 | EPHB2 | 0.69106706 |
79 | PRKAA2 | 0.68996980 |
80 | SGK1 | 0.68023985 |
81 | ARAF | 0.66578573 |
82 | BRAF | 0.66538021 |
83 | TBK1 | 0.66107696 |
84 | MYLK | 0.65382011 |
85 | JAK3 | 0.65341543 |
86 | FGFR4 | 0.65338409 |
87 | BCR | 0.65076776 |
88 | MAPK10 | 0.63083259 |
89 | DYRK3 | 0.62882890 |
90 | MAP2K6 | 0.62848856 |
91 | CAMK4 | 0.62333792 |
92 | AKT3 | 0.62152058 |
93 | ROCK1 | 0.60992776 |
94 | ZAP70 | 0.60941765 |
95 | ROCK2 | 0.58819820 |
96 | IRAK3 | 0.57959046 |
97 | PLK2 | 0.53661004 |
98 | RPS6KA3 | 0.53482063 |
99 | PRKG2 | 0.53141668 |
100 | EIF2AK3 | 0.52229806 |
101 | PRKCE | 0.51449381 |
102 | JAK2 | 0.50033577 |
103 | CDK11A | 0.50010478 |
104 | DDR2 | 0.49709714 |
105 | SGK3 | 0.48585946 |
106 | RET | 0.48372233 |
107 | IKBKE | 0.47721204 |
108 | STK11 | 0.47600451 |
109 | TLK1 | 0.46847672 |
110 | CSK | 0.46242473 |
111 | PRKG1 | 0.45439406 |
112 | CDK5 | 0.45070462 |
113 | BMPR2 | 0.41259139 |
114 | RPS6KA2 | 0.40338948 |
115 | PRKCI | 0.39438092 |
116 | NLK | 0.38992695 |
117 | DYRK1A | 0.38365420 |
118 | CAMK1G | 0.38131663 |
119 | PTK6 | 0.36616630 |
120 | WNK1 | 0.36205469 |
121 | CAMKK1 | 0.35655105 |
122 | IGF1R | 0.35202273 |
123 | DAPK2 | 0.35093084 |
124 | RIPK1 | 0.33831728 |
125 | ITK | 0.31615301 |
126 | JAK1 | 0.31442086 |
127 | GSK3A | 0.30237231 |
128 | PAK6 | 0.30039127 |
129 | CAMK2D | 0.29937838 |
130 | PRKACG | 0.28609760 |
131 | TGFBR2 | 0.28131959 |
132 | CAMK1 | 0.27255035 |
133 | CAMK2B | 0.26560787 |
134 | PDGFRB | 0.24307279 |
135 | TAOK3 | 0.24102801 |
136 | CDK9 | 0.22597890 |
137 | MAPK3 | 0.22356105 |
138 | PRKACA | 0.21940687 |
139 | PRKAA1 | 0.21689447 |
140 | PRKCG | 0.20812219 |
141 | PTK2B | 0.20520494 |
142 | CSNK1A1 | 0.20510104 |
143 | PRKD1 | 0.20242951 |
144 | CAMK1D | 0.19022463 |
145 | CHUK | 0.18724802 |
146 | GRK5 | 0.18685615 |
147 | ADRBK1 | 0.18475252 |
148 | DAPK1 | 0.17996196 |
149 | MAPK7 | 0.17522776 |
150 | STK16 | 0.16133437 |
151 | MAPK9 | 0.15397570 |
152 | IRAK2 | 0.15234121 |
153 | PDK2 | 0.14537720 |
154 | NEK6 | 0.13767157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.19362056 |
2 | Protein export_Homo sapiens_hsa03060 | 5.37148227 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.15264932 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 2.88798512 |
5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.60771819 |
6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.59059944 |
7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.30201310 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.29305672 |
9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.12559436 |
10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.90531667 |
11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79788115 |
12 | Cocaine addiction_Homo sapiens_hsa05030 | 1.73131053 |
13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61050236 |
14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.60566345 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51638852 |
16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50854668 |
17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38951869 |
18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38403793 |
19 | Lysosome_Homo sapiens_hsa04142 | 1.37713894 |
20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.36517481 |
21 | Bile secretion_Homo sapiens_hsa04976 | 1.33893339 |
22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32918206 |
23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.26732964 |
24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26391753 |
25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26307162 |
26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25364712 |
27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24035132 |
28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22566028 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19912285 |
30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19842951 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19678838 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17183359 |
33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17003921 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11378504 |
35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11111051 |
36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10799167 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07739738 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06557937 |
39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05039756 |
40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04711366 |
41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03060700 |
42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02523328 |
43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02461342 |
44 | Taste transduction_Homo sapiens_hsa04742 | 1.02342713 |
45 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99620698 |
46 | Insulin resistance_Homo sapiens_hsa04931 | 0.99431926 |
47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97831859 |
48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96628515 |
49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95021036 |
50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94697586 |
51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93816321 |
52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92099983 |
53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91038224 |
54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90366470 |
55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89140560 |
56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88767450 |
57 | Mineral absorption_Homo sapiens_hsa04978 | 0.88404843 |
58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88290756 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84384661 |
60 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.84170514 |
61 | Prion diseases_Homo sapiens_hsa05020 | 0.82776120 |
62 | ABC transporters_Homo sapiens_hsa02010 | 0.81268766 |
63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81016316 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79029726 |
65 | Phototransduction_Homo sapiens_hsa04744 | 0.77993966 |
66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77431066 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76832656 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76443254 |
69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76178178 |
70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75632653 |
71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74682219 |
72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73265241 |
73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73027829 |
74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72970667 |
75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72754692 |
76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72542216 |
77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72131960 |
78 | Renin secretion_Homo sapiens_hsa04924 | 0.70168090 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70065722 |
80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69980313 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68994619 |
82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68635398 |
83 | Tight junction_Homo sapiens_hsa04530 | 0.67928046 |
84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67250860 |
85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65495868 |
86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64368493 |
87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64247920 |
88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64008420 |
89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63348365 |
90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62743907 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59353786 |
92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58703614 |
93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57658095 |
94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57181961 |
95 | Melanogenesis_Homo sapiens_hsa04916 | 0.55888168 |
96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55878130 |
97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55753407 |
98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55743599 |
99 | Long-term depression_Homo sapiens_hsa04730 | 0.54901496 |
100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54896090 |
101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54768850 |
102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54524155 |
103 | Morphine addiction_Homo sapiens_hsa05032 | 0.53892069 |
104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53511101 |
105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53282266 |
106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51571600 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51482201 |
108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51024776 |
109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50574013 |
110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49554788 |
111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46865300 |
112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46395794 |
113 | Gap junction_Homo sapiens_hsa04540 | 0.45847538 |
114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45754266 |
115 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44500526 |
116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44060965 |
117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42015640 |
118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41182444 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40786648 |
120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40460893 |
121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39886975 |
122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39773177 |
123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37107927 |
124 | Alcoholism_Homo sapiens_hsa05034 | 0.35676967 |
125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33596779 |
126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33500714 |
127 | Salivary secretion_Homo sapiens_hsa04970 | 0.30980222 |
128 | Peroxisome_Homo sapiens_hsa04146 | 0.30670243 |
129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29432020 |
130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28111067 |
131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26170330 |
132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25955331 |
133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25238685 |
134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24917314 |
135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23722410 |
136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21540960 |
137 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.21473788 |
138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.20832574 |
139 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20112457 |
140 | Legionellosis_Homo sapiens_hsa05134 | 0.19803336 |
141 | Endocytosis_Homo sapiens_hsa04144 | 0.19583957 |
142 | Phagosome_Homo sapiens_hsa04145 | 0.19229836 |